TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens March 19, 1999
TCL Archive In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15 November 24, 1995
